序号 专利名 申请号 申请日 公开(公告)号 公开(公告)日 发明人
1 Novel Nucleotide and Amino Acid Sequences, and Assays and Methods of Use Thereof for Diagnosis of Cardiac Disease US12623957 2009-11-23 US20100248270A1 2010-09-30 Yossi Cohen; Alexander Diber; Amir Toporik; Sarah Pollock; Zurit Levine; Michal Ayalon-Soffer; Gad S. Cojocaru; Amit Novik; Guy Kol; Osnat Sella-Tavor; Shira Walach; Shirley Sameah-Greenwald; Dvir Dahary; Ronen Shemesh
Novel markers for cardiac disease that are both sensitive and accurate. These markers are differentially and/or specifically expressed in cardiac tissue, as opposed to other types of tissues, optionally and preferably including muscle tissue. The measurement of these markers, alone or in combination, in patient samples provides information that the diagnostician can correlate with a probable diagnosis of cardiac disease, including pathology and/or damage, including acute and/or chronic damage. The markers of the present invention, alone or in combination, show a high degree of differential detection between cardiac disease states and non-cardiac disease states.
2 Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of cardiac disease US11978203 2007-10-29 US07714100B2 2010-05-11 Yossi Cohen; Alexander Diber; Amir Toporik; Sarah Pollock; Zurit Levine; Michal Ayalon-Soffer; Gad S. Cojocaru; Amit Novik; Guy Kol; Osnat Sella-Tavor; Shira Walach; Shirley Sameah-Greenwald; Dvir Dahary; Ronen Shemesh
Novel markers for cardiac disease that are both sensitive and accurate. These markers are differentially and/or specifically expressed in cardiac tissue, as opposed to other types of tissues, optionally and preferably including muscle tissue. The measurement of these markers, alone or in combination, in patient samples provides information that the diagnostician can correlate with a probable diagnosis of cardiac disease, including pathology and/or damage, including acute and/or chronic damage. The markers of the present invention, alone or in combination, show a high degree of differential detection between cardiac disease states and non-cardiac disease states.
3 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of cardiac disease US11978203 2007-10-29 US20080193941A1 2008-08-14 Yossi Cohen; Alexander Diber; Amir Toporik; Sarah Pollock; Zurit Levine; Michal Avalon-Soffer; Gad S. Cojocaru; Amit Novik; Guy Kol; Osnat Sella-Tavor; Shira Walach; Shirley Sameah-Greenwald; Dvir Dahary; Ronen Shemesh
Novel markers for cardiac disease that are both sensitive and accurate. These markers are differentially and/or specifically expressed in cardiac tissue, as opposed to other types of tissues, optionally and preferably including muscle tissue. The measurement of these markers, alone or in combination, in patient samples provides information that the diagnostician can correlate with a probable diagnosis of cardiac disease, including pathology and/or damage, including acute and/or chronic damage. The markers of the present invention, alone or in combination, show a high degree of differential detection between cardiac disease states and non-cardiac disease states.
4 METHODS OF DETECTION AND TREATMENT FOR CARDIOVASCULAR DISEASE AND FOOT WOUNDS US15967719 2018-05-01 US20180321225A1 2018-11-08 Mohamed Zayed; Clay Semenkovich
Among the various aspects of the present disclosure is the provision of a method of detection, treatment, and monitoring of cardiovascular disease or a foot wound by detection of a novel biomarker, Fatty Acid Synthase (FAS).
5 Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of cardiac disease US11043824 2005-01-27 US07345142B2 2008-03-18 Yossi Cohen; Alexander Diber; Amir Toporik; Sarah Pollock; Zurit Levine; Michal Ayalon-Soffer; Gad S. Cojocaru; Amit Novik; Guy Kol; Osnat Sella-Tavor; Shira Walach; Shirley Sameah-Greenwald; Dvir Dahary; Ronen Shemesh
Novel markers for cardiac disease that are both sensitive and accurate. These markers are differentially and/or specifically expressed in cardiac tissue, as opposed to other types of tissues, optionally and preferably including muscle tissue. The measurement of these markers, alone or in combination, in patient samples provides information that the diagnostician can correlate with a probable diagnosis of cardiac disease, including pathology and/or damage, including acute and/or chronic damage. The markers of the present invention, alone or in combination, show a high degree of differential detection between cardiac disease states and non-cardiac disease states.
6 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of cardiac disease US11043824 2005-01-27 US20060172311A1 2006-08-03 Yossi Cohen; Alexander Diber; Amir Toporik; Sarah Pollock; Zurit Levine; Michal Ayalon-Soffer; Gad Cojocaru; Amit Novik; Guy Kol; Osnat Sella-Tavor; Shira Walach; Shirley Sameah-Greenwald; Dvir Dahary; Ronen Shemesh
Novel markers for cardiac disease that are both sensitive and accurate. These markers are differentially and/or specifically expressed in cardiac tissue, as opposed to other types of tissues, optionally and preferably including muscle tissue. The measurement of these markers, alone or in combination, in patient samples provides information that the diagnostician can correlate with a probable diagnosis of cardiac disease, including pathology and/or damage, including acute and/or chronic damage. The markers of the present invention, alone or in combination, show a high degree of differential detection between cardiac disease states and non-cardiac disease states.
QQ群二维码
意见反馈